Hosted on MSN17h
Rare Food Allergy Syndrome Increasingly Due to Early Egg, Peanut Introduction?
Common triggers for food protein-induced enterocolitis syndrome (FPIES) have shifted, and more cases than expected have ...
Injectable asthma drug resolves dangerous food allergies in one-third of children
More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...
Too Old to Operate5h
AAAAI: Omalizumab Superior to Oral Immunotherapy in Multifood Allergy
Omalizumab is superior to oral immunotherapy (OIT) for multifood allergy, and most patients include dietary consumption (DC) ...
KalVista Pharmaceuticals Shares Latest Sebetralstat Findings at the American Academy of Allergy, Asthma & Immunology 2025 Annual Meeting
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the presentation of novel sebetralstat data related to ...
Monthly Prescribing Reference17h
Omalizumab vs OIT: Head-to-Head Study Compares Food Allergy Treatments
Omalizumab was found to be more effective than multi-allergen oral immunotherapy (OIT) in reducing allergic reactions in patients with 1 or more food allergies, according to resul ...
Some kids may successfully eat trigger foods after stopping anti-allergy med, early study suggests
The study of success eating food triggers after stopping Xolair is ongoing, so researchers are still collecting data for doctors to use making treatment plans with their patients. Parents interested ...
Food Allergy Cure? This FDA-Approved Drug Helps Kids Eat Peanuts, Milk, And More!
A new clinical trial reveals that the asthma drug omalizumab (Xolair) helps food-allergic children eat trigger foods safely.
BioSpace22h
First Head-to-Head Study Cements Roche’s Xolair as Food Allergy Leader
Roche’s asthma drug Xolair appears to be safer and more effective than oral immunotherapy at treating adults and children ...
Daily Jang15h
Injectable asthma drug helps one-third of kids to overcome food allergies
A new study has revealed that the injectable asthma drug helped more than one-third of the kids to overcome their food ...
Healio1d
44% of patients with acute exacerbations of COPD have hypogammaglobulinemia
Immunoglobulin G hypogammaglobulinemia was found in 44.7% of patients with acute exacerbations of COPD receiving triple ...
Phase III Study Shows Xolair May Be More Effective With Fewer Side Effects Than Oral Immunotherapy for the Treatment of Food Allergies
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new positive data from Stage 2 and Stage ...
Pharvaris reports safety and efficacy data of deucrictibant
Pharvaris (PHVS) highlighted safety and efficacy data of deucrictibant, which is currently being evaluated in two pivotal Phase 3 studies, ...